Oaktree Acquisition Corp. III Life Sciences
OACC- Exchange
- Nasdaq
- Industry
- Blank Checks
- SEC CIK
- 0002029769
No open-market purchases or sales by Oaktree Acquisition Corp. III Life Sciences insiders were filed in the last 90 days; 51 institutions reported holding it in 13F filings for Q2 2026, worth $181.5M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Oaktree Acquisition Corp. III Life Sciences changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 39 | 1 | 47 | +9 |
| Shares | 15.0M | 200.0K | 16.5M | +1.69M (+11.4%) |
| Value | $153.2M | $2.02M | $172.4M | +$21.3M (+14.1%) |
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Oaktree Acquisition Corp. III Life Sciences at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Moore Capital Management, LP | 525,000 | $5.50M | 0.11% |
| Alberta Investment Management Corp | 500,000 | $5.24M | 0.04% |
| Governors Lane LP | 300,000 | $3.13M | 0.43% |
| Whitebox Advisors LLC | 250,000 | $2.61M | 0.07% |
| JPMorgan Chase & Co | 199,776 | $2.09M | 0.00% |
| Mizuho Securities USA LLC | 159,991 | $1.66M | 0.04% |
| Radcliffe Capital Management, L.P. | 81,913 | $856.0K | 0.07% |
| Meteora Capital, LLC | 49,500 | $517.3K | 0.10% |
| Virtu Financial LLC | 47,048 | $493.0K | 0.03% |
| Fifth Lane Capital, LP | 34,000 | $356.3K | 0.43% |
| Bardin Hill Management Partners LP | 12,305 | $128.6K | 0.08% |
| UBS Group AG | 10 | $105 | 0.00% |
Sold out (3)
Institutions that held Oaktree Acquisition Corp. III Life Sciences at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Harraden Circle Investments, LLC | 502,500 | $5.14M |
| ExodusPoint Capital Management, LP | 293,153 | $3.00M |
| Citadel Advisors LLC | 14,904 | $152.0K |
Not filed for Q2 2025 yet (1)
Institutions that held Oaktree Acquisition Corp. III Life Sciences at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Mizuho Securities USA LLC | 200,000 | $2.02M |